Related Experiment Video
Updated: May 28, 2026

Venous Thrombosis Assay in a Mouse Model of Cancer
Published on: January 5, 2024
Thrombosis and malignancy: a case-based review
David Garcia1, Dulcinea Quintana
1Division of Hematology/Oncology, University of New Mexico Cancer Center, Albuquerque, NM 87131, USA. davgarcia@salud.unm.edu
Abstract:
The association between venous thromboembolism (VTE) and malignancy is well established. Recent interest has focused on standards of care for prophylaxis, diagnosis, and treatment of malignancy-associated thrombosis. Anticoagulant management in cancer patients has unique complexities such as prolonged hospitalization, extensive surgeries, extended periods of inactivity, indwelling central venous catheters (CVC), thrombocytopenia, and pro-thrombotic medications. Here we will explore current recommendations for various specific clinical scenarios for cancer-associated thromboses. We will make evidence-based recommendations wherever possible; however, several of the scenarios here were included because pertinent high-quality evidence does not exist.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction